Former In-House Global IP Head Pivots To Smith Gambrell
Smith Gambrell Russell LLP has added the former global head of an animal health biotech and pharmaceutical company, bringing to the Atlanta office a former scientist who developed a canine vaccine against Lyme disease....To view the full article, register now.
Already a subscriber? Click here to view full article